Skip to content

Ersilia Model Hub

A curated set of AI/ML models for drug discovery research in low- and middle-income countries.

Overview

Link
Website

More Information

Ersilia uses AI to support researchers working in resource-limited countries. Together, they develop tools to speed up experiments and reduce the cost of developing new drugs.

Ersilia is building the first AI-powered, open-source tool to streamline the generation of antimicrobial drug candidates, focusing on neglected tropical diseases that affect the Global South. It is growing a community of open science enthusiasts collectively contributing to free, accessible AI tools for research; supporting students, early career researchers, and principal investigators in their active research projects; and equipping drug discovery centers in the Global South with AI infrastructure to enhance their research capabilities.

Contribute

Join the Discord

Contributors

About Gemma

Gemma is the Co-Founder and CEO of Ersilia. She holds a PhD and MSc in Biomedicine from the University of Barcelona.

About Miquel

Miquel is the Chief Scientific Officer and Co-Founder at Ersilia. His research interests lie at the intersection between drug discovery and large-scale biological data analysis. He has held positions at IRB Barcelona, the Massachusetts Institute of Technology (MIT), Tel Aviv University, ISGlobal-CISM (Mozambique), and CIDRZ (Zambia). He holds an MSc in Bioinformatics and a PhD in Biomedicine from Pompeu Fabra University, as well as a BSc in Chemistry from Ramon Llull University.

More from Miquel

About Dhanshree

Dhanshree Arora is the CTO of Ersilia. She previously served as an ML Engineer at Eder Labs and Data Scientist at SpotDraft.

Other Projects